Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies

OBJECTIVE To develop and validate a tool for Alzheimer's disease (AD) diagnosis in individual subjects using support vector machine (SVM)-based classification of structural MR (sMR) images. BACKGROUND Libraries of sMR scans of clinically well characterized subjects can be harnessed for the purpose of diagnosing new incoming subjects. METHODS One hundred ninety patients with probable AD were age- and gender-matched with 190 cognitively normal (CN) subjects. Three different classification models were implemented: Model I uses tissue densities obtained from sMR scans to give STructural Abnormality iNDex (STAND)-score; and Models II and III use tissue densities as well as covariates (demographics and Apolipoprotein E genotype) to give adjusted-STAND (aSTAND)-score. Data from 140 AD and 140 CN were used for training. The SVM parameter optimization and training were done by four-fold cross validation (CV). The remaining independent sample of 50 AD and 50 CN was used to obtain a minimally biased estimate of the generalization error of the algorithm. RESULTS The CV accuracy of Model II and Model III aSTAND-scores was 88.5% and 89.3%, respectively, and the developed models generalized well on the independent test data sets. Anatomic patterns best differentiating the groups were consistent with the known distribution of neurofibrillary AD pathology. CONCLUSIONS This paper presents preliminary evidence that application of SVM-based classification of an individual sMR scan relative to a library of scans can provide useful information in individual subjects for diagnosis of AD. Including demographic and genetic information in the classification algorithm slightly improves diagnostic accuracy.

[1]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[2]  Nick C. Fox,et al.  Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates , 2004, NeuroImage.

[3]  Keith A. Johnson,et al.  Neuropathology of Cognitively Normal Elderly , 2003, Journal of neuropathology and experimental neurology.

[4]  Fabrice Crivello,et al.  Age- and sex-related effects on the neuroanatomy of healthy elderly , 2005, NeuroImage.

[5]  J. Morris,et al.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage alzheimer’s disease , 2001, Journal of Molecular Neuroscience.

[6]  Alberto Beltramello,et al.  A comparison between the accuracy of voxel‐based morphometry and hippocampal volumetry in Alzheimer's disease , 2004, Journal of magnetic resonance imaging : JMRI.

[7]  David G. Stork,et al.  Pattern Classification , 1973 .

[8]  Nico Karssemeijer,et al.  Computer-Aided Diagnosis in Medical Imaging , 2001, IEEE Trans. Medical Imaging.

[9]  R. Katzman.,et al.  Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques , 1988, Annals of neurology.

[10]  Nick C Fox,et al.  Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. , 1998, Journal of computer assisted tomography.

[11]  Robert Tibshirani,et al.  The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd Edition , 2001, Springer Series in Statistics.

[12]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[13]  Jason Weston,et al.  Learning Gene Functional Classifications from Multiple Data Types , 2002, J. Comput. Biol..

[14]  F. Schmitt,et al.  Age and gender effects on human brain anatomy: A voxel-based morphometric study in healthy elderly , 2007, Neurobiology of Aging.

[15]  平田 容子,et al.  Voxel-based morphometry to discriminate early Alzheimer's disease from controls , 2007 .

[16]  Nello Cristianini,et al.  An introduction to Support Vector Machines , 2000 .

[17]  Charles DeCarli,et al.  Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment , 2005 .

[18]  Margaret A. Pericak-Vance,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease , 1997 .

[19]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[20]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[21]  W. Markesbery,et al.  Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study , 2002, Annals of neurology.

[22]  Steven D. Edland,et al.  Accelerated decline in apolipoprotein E-ϵ4 homozygotes with Alzheimer's disease , 1998, Neurology.

[23]  E. Bigler,et al.  Dementia, quantitative neuroimaging, and apolipoprotein E genotype. , 2000, AJNR. American journal of neuroradiology.

[24]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[25]  M. Sliwinski,et al.  Pathological markers associated with normal aging and dementia in the elderly , 1993, Annals of neurology.

[26]  Vladimir Vapnik,et al.  Statistical learning theory , 1998 .

[27]  Marko Grobelnik,et al.  Feature selection using linear classifier weights: interaction with classification models , 2004, SIGIR '04.

[28]  Dinggang Shen,et al.  Classification of Structural Images via High-Dimensional Image Warping, Robust Feature Extraction, and SVM , 2005, MICCAI.

[29]  T. J. Grabowski,et al.  Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia , 2007 .

[30]  E B Larson,et al.  Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. , 1998, Neurology.

[31]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[32]  H. Braak,et al.  Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder , 1994, Neurobiology of Aging.

[33]  Miguel Ángel Martínez,et al.  Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. , 1997, American journal of human genetics.

[34]  Richard Simon,et al.  Bias in error estimation when using cross-validation for model selection , 2006, BMC Bioinformatics.

[35]  D. Mash,et al.  Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. , 1998, Journal of neuropathology and experimental neurology.

[36]  D. Schaid,et al.  Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.

[37]  Isabelle Guyon,et al.  An Introduction to Variable and Feature Selection , 2003, J. Mach. Learn. Res..

[38]  Masayuki Matsuda,et al.  Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease , 2006, NeuroImage.

[39]  A. Toga,et al.  Tracking Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.

[40]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[41]  Charles DeCarli,et al.  Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. , 2005, Archives of neurology.

[42]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[43]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[44]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[45]  M. Filippi,et al.  The contribution of voxel-based morphometry in staging patients with mild cognitive impairment , 2006, Neurology.

[46]  Dinggang Shen,et al.  Morphological classification of brains via high-dimensional shape transformations and machine learning methods , 2004, NeuroImage.

[47]  Michael I. Miller,et al.  Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly , 2005, NeuroImage.

[48]  G. Alexander,et al.  Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: A principal component approach to modeling brain function in disease , 1994 .

[49]  Nick C. Fox,et al.  MR image texture analysis applied to the diagnosis and tracking of Alzheimer's disease , 1998, IEEE Transactions on Medical Imaging.

[50]  J. Ashford,et al.  “Preclinical” AD revisited , 2000, Neurology.

[51]  Dinggang Shen,et al.  Classifying spatial patterns of brain activity with machine learning methods: Application to lie detection , 2005, NeuroImage.

[52]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .